Teva gets generic Zoloft OK (and Lexapro, too!)
Oh those crazy Israelis, constantly beating other generic drugmakers to that six month, government-granted generic drug monopoly. They've done it again with Zoloft, which was approved by the FDA on Friday.
Sucks to be Pfizer, of course. Zoloft is a super profitable drug ($3.1 billion) and enjoyed the #7 spot on the top 200 list last year.
Teva will also enjoy a six-month monopoly on Lexapro when its time comes in December 2009.
I really can't wait to see what (if anything) Novartis does with their Sandoz unit in protecting their intellectual property investments from fast-moving, hard-driving competition from generic hardballers like Teva.
[tags]Medicine, pharmacy, Teva, Zoloft, sertraline, Lexapro, escitalopram, generic drugs[/tags]
1 Comment »
RSS feed for comments on this post.
| TrackBack URI
You can also bookmark
this on del.icio.us or check the cosmos
[...] Details are scant, but Teva has finally launched their generic sertraline. First to file an ANDA, they get the lock-up on the market for the next 180 days, unless Pfizer teams up with someone to launch an "authorized" generic. [...]
Pingback by Teva launches generic Zoloft (finally) :: OnThePharm — August 14, 2006 @ 1:34 pm